| Year |
Citation |
Score |
| 2020 |
Bastos ML, Campbell JR, Oxlade O, Adjobimey M, Trajman A, Ruslami R, Kim HJ, Baah JO, Toelle BG, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Apriani L, Benedetti A, et al. Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings. Annals of Internal Medicine. PMID 32539440 DOI: 10.7326/M19-3741 |
0.305 |
|
| 2020 |
Alsdurf H, Oxlade O, Adjobimey M, Ahmad Khan F, Bastos M, Bedingfield N, Benedetti A, Boafo D, Buu TN, Chiang L, Cook V, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, et al. Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries. Bmc Health Services Research. 20: 341. PMID 32316963 DOI: 10.1186/S12913-020-05220-7 |
0.32 |
|
| 2020 |
Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet. Respiratory Medicine. PMID 32192585 DOI: 10.1016/S2213-2600(20)30047-3 |
0.329 |
|
| 2020 |
Ronald LA, FitzGerald JM, Bartlett-Esquilant G, Schwartzman K, Benedetti A, Boivin JF, Menzies D. Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs. The European Respiratory Journal. PMID 31980498 DOI: 10.1183/13993003.02048-2019 |
0.718 |
|
| 2020 |
Fox GJ, Nguyen CB, Nguyen TA, Tran PT, Marais BJ, Graham SM, Nguyen BH, Velen K, Dowdy DW, Mason P, Britton WJ, Behr MA, Benedetti A, Menzies D, Nguyen VN, et al. Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial. Bmj Open. 10: e033945. PMID 31900274 DOI: 10.1136/Bmjopen-2019-033945 |
0.341 |
|
| 2019 |
Wang G, Schnitzer ME, Menzies D, Viiklepp P, Holtz TH, Benedetti A. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis. Biometrics. PMID 31868919 DOI: 10.1111/Biom.13210 |
0.33 |
|
| 2019 |
Campbell JR, Trajman A, Cook VJ, Johnston JC, Adjobimey M, Ruslami R, Eisenbeis L, Fregonese F, Valiquette C, Benedetti A, Menzies D. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials. The Lancet. Infectious Diseases. PMID 31866327 DOI: 10.1016/S1473-3099(19)30575-4 |
0.309 |
|
| 2019 |
Abidi S, Achar J, Neino MMA, Bang D, Benedetti A, Brode S, Campbell JR, Casas E, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, et al. Standardised shorter regimens individualised longer regimens for multidrug-resistant TB. The European Respiratory Journal. PMID 31862767 DOI: 10.1183/13993003.01467-2019 |
0.34 |
|
| 2019 |
Oxlade O, Trajman A, Benedetti A, Adjobimey M, Cook VJ, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Hill PC, Johnston J, Long R, Obeng J, Ruslami R, Valiquette C, et al. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial. Bmj Open. 9: e025831. PMID 30898826 DOI: 10.1136/Bmjopen-2018-025831 |
0.361 |
|
| 2018 |
Romanowski K, Balshaw RF, Benedetti A, Campbell JR, Menzies D, Ahmad Khan F, Johnston JC. Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis. Thorax. PMID 30420407 DOI: 10.1136/Thoraxjnl-2017-211120 |
0.353 |
|
| 2018 |
Siddique AA, Schnitzer ME, Bahamyirou A, Wang G, Holtz TH, Migliori GB, Sotgiu G, Gandhi NR, Vargas MH, Menzies D, Benedetti A. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis. Statistical Methods in Medical Research. 962280218808817. PMID 30381005 DOI: 10.1177/0962280218808817 |
0.307 |
|
| 2018 |
Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England). 392: 821-834. PMID 30215381 DOI: 10.1016/S0140-6736(18)31644-1 |
0.344 |
|
| 2018 |
Menzies D, Adjobimey M, Ruslami R, Trajman A, Sow O, Kim H, Obeng Baah J, Marks GB, Long R, Hoeppner V, Elwood K, Al-Jahdali H, Gninafon M, Apriani L, Koesoemadinata RC, ... ... Benedetti A, et al. Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults. The New England Journal of Medicine. 379: 440-453. PMID 30067931 DOI: 10.1056/Nejmoa1714283 |
0.358 |
|
| 2018 |
Diallo T, Adjobimey M, Ruslami R, Trajman A, Sow O, Obeng Baah J, Marks GB, Long R, Elwood K, Zielinski D, Gninafon M, Wulandari DA, Apriani L, Valiquette C, Fregonese F, ... ... Benedetti A, et al. Safety and Side Effects of Rifampin versus Isoniazid in Children. The New England Journal of Medicine. 379: 454-463. PMID 30067928 DOI: 10.1056/Nejmoa1714284 |
0.325 |
|
| 2018 |
Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, et al. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. The Lancet. Respiratory Medicine. 6: 265-275. PMID 29595509 DOI: 10.1016/S2213-2600(18)30078-X |
0.324 |
|
| 2018 |
Dehghani K, Lan Z, Li P, Michelsen SW, Waites S, Benedetti A, Lejeune P, Torrie J, Robinson E, Vejvoda B, Mullah M, Redwood D, Cooper M, Fanning A, Yacoub W, et al. Determinants of tuberculosis trends in six Indigenous populations of the USA, Canada, and Greenland from 1960 to 2014: a population-based study. The Lancet. Public Health. PMID 29426597 DOI: 10.1016/S2468-2667(18)30002-1 |
0.301 |
|
| 2017 |
Ahmad Khan F, Salim MAH, du Cros P, Casas EC, Khamraev A, Sikhondze W, Benedetti A, Bastos M, Lan Z, Jaramillo E, Falzon D, Menzies D. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses. The European Respiratory Journal. 50. PMID 28751411 DOI: 10.1183/13993003.00061-2017 |
0.36 |
|
| 2017 |
Levis B, Benedetti A, Levis AW, Ioannidis JPA, Shrier I, Cuijpers P, Gilbody S, Kloda LA, McMillan D, Patten SB, Steele RJ, Ziegelstein RC, Bombardier CH, de Lima Osório F, Fann JR, et al. Selective Cutoff Reporting in Studies of Diagnostic Test Accuracy: A Comparison of Conventional and Individual-Patient-Data Meta-Analyses of the Patient Health Questionnaire-9 Depression Screening Tool. American Journal of Epidemiology. 1-11. PMID 28419203 DOI: 10.1093/Aje/Kww191 |
0.326 |
|
| 2017 |
Ronald LA, Ling DI, FitzGerald JM, Schwartzman K, Bartlett-Esquilant G, Boivin JF, Benedetti A, Menzies D. Validated methods for identifying tuberculosis patients in health administrative databases: systematic review. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 21: 517-522. PMID 28399966 DOI: 10.5588/ijtld.16.0588 |
0.721 |
|
| 2017 |
Fox GJ, Benedetti A, Cox H, Koh WJ, Viiklepp P, Ahuja S, Pasvol G, Menzies D. Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis. The European Respiratory Journal. 49. PMID 28049171 DOI: 10.1183/13993003.00993-2016 |
0.347 |
|
| 2016 |
Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. The Lancet. Infectious Diseases. PMID 27865891 DOI: 10.1016/S1473-3099(16)30407-8 |
0.318 |
|
| 2016 |
Ronald LA, FitzGerald JM, Benedetti A, Boivin JF, Schwartzman K, Bartlett-Esquilant G, Menzies D. Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study. Bmc Infectious Diseases. 16: 679. PMID 27846812 DOI: 10.1186/S12879-016-1997-X |
0.717 |
|
| 2016 |
Fox GJ, Benedetti A, Mitnick CD, Pai M, Menzies D. Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis. Plos One. 11: e0151724. PMID 27022741 DOI: 10.1371/Journal.Pone.0151724 |
0.369 |
|
| 2016 |
Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, et al. Surgery as an adjunctive treatment for multi-drug resistant tuberculosis: an individual patient data meta-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26757804 DOI: 10.1093/Cid/Ciw002 |
0.33 |
|
| 2015 |
Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K. Health-related quality of life and tuberculosis: a longitudinal cohort study. Health and Quality of Life Outcomes. 13: 65. PMID 26012563 DOI: 10.1186/S12955-015-0250-4 |
0.338 |
|
| 2015 |
Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K. The impact of tuberculosis on health utility: a longitudinal cohort study. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 24: 1337-49. PMID 25391490 DOI: 10.1007/S11136-014-0858-6 |
0.356 |
|
| 2014 |
Thombs BD, Benedetti A, Kloda LA, Levis B, Nicolau I, Cuijpers P, Gilbody S, Ioannidis JP, McMillan D, Patten SB, Shrier I, Steele RJ, Ziegelstein RC. The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses. Systematic Reviews. 3: 124. PMID 25348422 DOI: 10.1186/2046-4053-3-124 |
0.328 |
|
| 2014 |
Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 14: 947-57. PMID 25108337 DOI: 10.1016/S1473-3099(14)70852-7 |
0.334 |
|
| 2014 |
Thomas D, Radji S, Benedetti A. Systematic review of methods for individual patient data meta- analysis with binary outcomes. Bmc Medical Research Methodology. 14: 79. PMID 24943877 DOI: 10.1186/1471-2288-14-79 |
0.318 |
|
| 2014 |
Sotgiu G, Mauch V, Migliori GB, Benedetti A. Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster. The European Respiratory Journal. 43: 1563-6. PMID 24881058 DOI: 10.1183/09031936.00064314 |
0.348 |
|
| 2014 |
Law S, Benedetti A, Oxlade O, Schwartzman K, Menzies D. Comparing cost-effectiveness of standardised tuberculosis treatments given varying drug resistance. The European Respiratory Journal. 43: 566-81. PMID 23766335 DOI: 10.1183/09031936.00005613 |
0.334 |
|
| 2013 |
Bhargava A, Chatterjee M, Jain Y, Chatterjee B, Kataria A, Bhargava M, Kataria R, D'Souza R, Jain R, Benedetti A, Pai M, Menzies D. Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. Plos One. 8: e77979. PMID 24205052 DOI: 10.1371/Journal.Pone.0077979 |
0.338 |
|
| 2013 |
Zwerling A, Joshi R, Kalantri SP, Dakshinamoorthy G, Reddy MV, Benedetti A, Schwartzman K, Menzies D, Pai M. Trajectories of tuberculosis-specific interferon-gamma release assay responses among medical and nursing students in rural India. Journal of Epidemiology and Global Health. 3: 105-17. PMID 23856572 DOI: 10.1016/J.Jegh.2013.03.003 |
0.316 |
|
| 2013 |
Migliori GB, Sotgiu G, Gandhi NR, Falzon D, DeRiemer K, Centis R, Hollm-Delgado MG, Palmero D, Pérez-Guzmán C, Vargas MH, D'Ambrosio L, Spanevello A, Bauer M, Chan ED, Schaaf HS, ... ... Benedetti A, et al. Drug resistance beyond extensively drugresistant tuberculosis: Individual patient data meta-analysis European Respiratory Journal. 42: 169-179. PMID 23060633 DOI: 10.1183/09031936.00136312 |
0.339 |
|
| 2012 |
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, Becerra MC, Benedetti A, Burgos M, Centis R, Chan ED, Chiang CY, Cox H, D'Ambrosio L, DeRiemer K, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. Plos Medicine. 9: e1001300. PMID 22952439 DOI: 10.1371/Journal.Pmed.1001300 |
0.359 |
|
| 2012 |
Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M. TB screening in Canadian health care workers using interferon-gamma release assays. Plos One. 7: e43014. PMID 22916197 DOI: 10.1371/Journal.Pone.0043014 |
0.306 |
|
| 2012 |
Ahmad Khan F, Minion J, Al-Motairi A, Benedetti A, Harries AD, Menzies D. An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 1154-63. PMID 22820541 DOI: 10.1093/Cid/Cis630 |
0.342 |
|
| 2011 |
Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis [Review article]. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 15: 1018-1032. PMID 29070295 DOI: 10.5588/Ijtld.10.0631 |
0.324 |
|
| 2010 |
Oxlade O, Schwartzman K, Pai M, Heymann J, Benedetti A, Royce S, Menzies D. Predicting outcomes and drug resistance with standardised treatment of active tuberculosis. The European Respiratory Journal. 36: 870-7. PMID 20351030 DOI: 10.1183/09031936.00151709 |
0.334 |
|
| 2009 |
Menzies D, Benedetti A, Paydar A, Royce S, Madhukar P, Burman W, Vernon A, Lienhardt C. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. Plos Medicine. 6: e1000150. PMID 20101802 DOI: 10.1371/Journal.Pmed.1000150 |
0.356 |
|
| 2009 |
Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, Vernon A, Lienhardt C, Burman W. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. Plos Medicine. 6: e1000146. PMID 19753109 DOI: 10.1371/Journal.Pmed.1000146 |
0.36 |
|
| 2009 |
Benedetti A, Abrahamowicz M, Leffondr K, Goldberg MS, Tamblyn R. Using generalized additive models to detect and estimate threshold associations International Journal of Biostatistics. 5. DOI: 10.2202/1557-4679.1172 |
0.451 |
|
| 2009 |
Benedetti A, Abrahamowicz M, Goldberg MS. Accounting for Data-Dependent Degrees of Freedom Selection When Testing the Effect of a Continuous Covariate in Generalized Additive Models Communications in Statistics - Simulation and Computation. 38: 1115-1135. DOI: 10.1080/03610910902796032 |
0.443 |
|
| 2008 |
Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K. Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial. Annals of Internal Medicine. 149: 689-97. PMID 19017587 DOI: 10.7326/0003-4819-149-10-200811180-00003 |
0.312 |
|
| 2004 |
Benedetti A, Abrahamowicz M. Using generalized additive models to reduce residual confounding. Statistics in Medicine. 23: 3781-801. PMID 15580601 DOI: 10.1002/Sim.2073 |
0.465 |
|
| Show low-probability matches. |